Your browser doesn't support javascript.
loading
Modified outpatient dexamethazone, cytarabine and cisplatin regimen may lead to high response rates and low toxicity in lymphoma.
Kanat, Ozkan; Ozet, Ahmet; Ataergin, Selmin; Arpaci, Fikret; Kuzhan, Okan; Komurcu, Seref; Ozturk, Bekir; Ozturk, Mustafa.
Affiliation
  • Kanat O; Department of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey.
Med Princ Pract ; 19(5): 344-7, 2010.
Article in En | MEDLINE | ID: mdl-20639655
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Outpatients / Lymphoma, Non-Hodgkin / Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Med Princ Pract Journal subject: EDUCACAO Year: 2010 Document type: Article Affiliation country: Turquía Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Outpatients / Lymphoma, Non-Hodgkin / Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Med Princ Pract Journal subject: EDUCACAO Year: 2010 Document type: Article Affiliation country: Turquía Country of publication: Suiza